Evidence map›Paper›PMID 36831541›Full record

ArticleCancers2023

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.

Bálint Cserni, Darren Kilmartin, Mark O'Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi, Ewa Chmielik, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini and 27 more

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Targeting low-risk triple-negative breast cancer: a review on de-escalation strategies for a new era.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Bálint CserniTNG Technology Consulting GmbH, Király u. 26., 1061 Budapest, Hungary.
Darren KilmartinDiscipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.
Mark O'LoughlinDiscipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.
Xavier AndreuPathology Department, Atryshealth Co., Ltd., 08039 Barcelona, Spain.
Zsuzsanna Bagó-HorváthDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
Simonetta BianchiDivision of Pathological Anatomy, Department of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-2605-4758
Ewa ChmielikTumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Paulo FigueiredoLaboratório de Anatomia Patológica, IPO Coimbra, 3000-075 Coimbra, Portugal.
Giuseppe FlorisLaboratory of Translational Cell & Tissue Research and KU Leuven, Department of Imaging and Pathology, Department of Pathology, University Hospitals Leuven, University of Leuven, Oude Market 13, 3000 Leuven, Belgium.
Maria Pia FoschiniUnit of Anatomic Pathology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bellaria Hospital, 40139 Bologna, Italy.ORCID 0000-0001-7079-7260
Anikó KovácsDepartment of Clinical Pathology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.ORCID 0000-0001-7711-4418
Päivi HeikkiläDepartment of Pathology, Helsinki University Central Hospital, 00029 Helsinki, Finland.
Janina KulkaDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University Budapest, Üllői út 93, 1091 Budapest, Hungary.
Anne-Vibeke LaenkholmDepartment of Surgical Pathology, Zealand University Hospital, 4000 Roskilde, Denmark.
Inta Liepniece-KareleDepartment of Pathology, Riga Stradins University, Riga East Clinical University Hospital, LV-1038 Riga, Latvia.
Caterina MarchiòUnit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0003-2024-6131
Elena ProvenzanoDepartment of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge CB2 0QQ, UK.
Peter RegitnigDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-1371-1595
Angelika ReinerDepartment of Pathology, Klinikum Donaustadt, 1090 Vienna, Austria.
Aleš RyškaThe Fingerland Department of Pathology, Charles University Medical Faculty and University Hospital, 50003 Hradec Kralove, Czech Republic.
Anna SapinoUnit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy.
Elisabeth Specht StovgaardPathology Department, Herlev University Hospital, DK-2730 Herlev, Denmark.ORCID 0000-0002-5784-3610
Cecily QuinnDepartment of Histopathology, Irish National Breast Screening Programme, BreastCheck, St. Vincent's University Hospital and School of Medicine, University College Dublin, D04 T6F4 Dublin, Ireland.
Vasiliki ZolotaDepartment of Pathology, School of Medicine, University of Patras, 26504 Rion, Greece.
Mark WebberDiscipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.
Sharon A GlynnDiscipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.ORCID 0000-0003-1459-2580
Rita BoriDepartment of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.
Erika CsörgőDepartment of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.
Orsolya Oláh-NémethDepartment of Pathology, University of Szeged, 6720 Szeged, Hungary.
Tamás PancsaDepartment of Pathology, University of Szeged, 6720 Szeged, Hungary.
Anita SejbenDepartment of Pathology, University of Szeged, 6720 Szeged, Hungary.
István SejbenDepartment of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.
András VörösDepartment of Pathology, University of Szeged, 6720 Szeged, Hungary.
Tamás ZomboriDepartment of Pathology, University of Szeged, 6720 Szeged, Hungary.
Tibor NyáriDepartment of Medical Physics and Informatics, University of Szeged, 6720 Szeged, Hungary.
Grace CallagyDiscipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.
Gábor CserniDepartment of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.

Indexed as

breast cancerEuropean Working Group for Breast Screening Pathologyinternational immuno-oncology biomarker working groupobservers needed to evaluate subjective testsONESTreproducibilitysTILsTILstriple-negativetumour-infiltrating lymphocytes

Identifiers

PMID36831541
PMCPMC9954449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.